Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates
Article in Toxicology and Applied Pharmacology (May 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
NK cell exhaustion in the tumor microenvironment
Article in Frontiers in Immunology (November 2023)
XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour models
Article in Cancer Immunology, Immunotherapy (October 2023)